NO EVIDENCE TO SUPPORT THE EXISTENCE OF A SMOKER’S PARADOX IN ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION MANAGED BY PRIMARY PERCUTANEOUS CORONARY INTERVENTION  by Steele, Lloyd et al.
Prevention
A1380
JACC March 17, 2015
Volume 65, Issue 10S
no eviDence to suppoRt tHe existence of a sMokeR’s paRaDox in acute st-segMent 
elevation MyocaRDial infaRction ManageD by pRiMaRy peRcutaneous coRonaRy 
inteRvention
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 10:00 a.m.-10:45 a.m.
Session Title: Lipids, Novel Therapies and Acute Coronary Syndromes
Abstract Category: 21.  Prevention: Clinical
Presentation Number: 1107-115
Authors: Lloyd Steele, Amelia Lloyd, James Fotheringham, Ayyaz Sultan, Javaid Iqbal, Ever Grech, University of Sheffield, Sheffield, 
United Kingdom, Northern General Hospital, Sheffield, United Kingdom
background:  Several studies have shown that in acute coronary syndrome, smokers have a lower mortality than non-smokers. This 
has been referred to as the “smoker’s paradox”. However, to date, no large, single-centre registry study involving patients with acute ST-
segment elevation myocardial infarction (STEMI) managed by primary percutaneous coronary intervention (PCI) has compared outcomes 
in smokers vs. non-smokers.
Methods:  All patients admitted with acute STEMI undergoing primary PCI in South Yorkshire, England, UK between 01/01/2009 and 
06/04/2012 were studied. The survival status for all patients at 1-year post-STEMI was obtained. Differences in survival by smoking status 
were assessed using a Kaplan-Meier curve, and differences in survival by smoking after adjustment for age and gender using a Cox 
regression analysis.
Results:  There were 1715 STEMIs in 1680 patients during the study time period. 49.1% were smokers, 27.2% were ex-smokers, and 
23.7% were never smokers. 114 patients (6.6%) had died after one year. The smoking status for 99 deceased patients (87%) and 1562 
surviving patients (98%) was obtained. Smokers tended to have a better post-STEMI 1-year survival than never smokers and ex-smokers, 
although the difference was not statistically significant (log-rank p=0.40). However, age was a significant confounder (P=0.001), and 
smokers presented approximately 10 years younger on average (57.2 years (95% CI 56.4-58.0)) than never (66.3 years (65.2-67.6)) and 
ex-smokers (67.9 years (66.8-69.0)). After adjustment for age and gender, smokers appeared to have a worse 1 year survival (hazard ratio 
1.30 (95% CI 0.77-2.2)) than ex-smokers (hazard ratio 1.03 (0.61-1.75) and never smokers (hazard ratio 1.0), although again the difference 
was not statistically significant (p=0.55).
conclusion:  In this large, single-centre registry of STEMI patients managed by primary PCI, we did not find any evidence of “smoker’s 
paradox”. After age and gender adjustment, a non-significant tendency towards a worse 1-year survival was seen in smokers.
